Earnings History Data for Horizon Therapeutics Public Limited Company (HZNP) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Horizon Therapeutics Public Limited Company

Horizon Therapeutics PLC is a biopharmaceutical company. It is focused on identifying, developing, acquiring and commercializing differentiated and accessible medicines which address unmet medical needs. The Company markets medicines through its orphan, rheumatology and primary care business units. Horizon Therapeutics PLC, formerly known as Horizon Pharma Public Limited Company, is headquartered in Dublin, Ireland.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
08-08-2023	PM		HZNP	Horizon Therapeutics Public Limited Company	22,890	1.20	1.12	1.07	Horizon Therapeutics Non-GAAP EPS of $1.20 beats by $0.23, revenue of $945M beats by $71.49M [8/8/2023 7:05 AM]	104.05	2.91 (2.87%)	102.75	1.61 (1.59%)	57.84 - 113.83	3,503,785	1,580,000	29,318
Horizon Therapeutics Q2 2023 Earnings Preview [8/7/2023 1:28 PM] Horizon Therapeutics Non-GAAP EPS of $1.20 beats by $0.23, revenue of $945M beats by $71.49M [8/8/2023 7:05 AM]
03-05-2023	PM	7:00 AM ET (May 3)	HZNP	Horizon Therapeutics Public Limited Company	25,570	0.83	1.17	1.34	Horizon Therapeutics Non-GAAP EPS of $0.83 misses by $0.37, revenue of $832.1M misses by $64.96M [5/3/2023 7:03 AM]	110.66	-1.10 (-0.98%)	110.75	-1.01 (-0.90%)	57.84 - 113.83	1,110,783	1,580,000	65,084
Horizon Therapeutics Q1 2023 Earnings Preview [5/2/2023 1:03 PM] Horizon Therapeutics Non-GAAP EPS of $0.83 misses by $0.37, revenue of $832.1M misses by $64.96M [5/3/2023 7:03 AM] Horizon Therapeutics Q1 miss irrelevant, deal still likely to close - analyst [5/3/2023 12:11 PM]
01-03-2023	PM	7:00 AM ET (Mar 1)	HZNP	Horizon Therapeutics Public Limited Company	25,300	1.21	1.09	1.41	Horizon Therapeutics Non-GAAP EPS of $1.21 beats by $0.12, revenue of $942M beats by $19.05M [3/1/2023 7:05 AM]	110.39	0.90 (0.82%)	109.16	-0.33 (-0.30%)	57.84 - 117.49	1,896,413	1,870,000	44,730
Horizon Therapeutics Q4 2022 Earnings Preview [2/28/2023 12:55 PM] Horizon Therapeutics Non-GAAP EPS of $1.21 beats by $0.12, revenue of $942M beats by $19.05M [3/1/2023 7:05 AM]
02-11-2022	PM	7:00 AM ET (Nov 2)	HZNP	Horizon Therapeutics Public Limited Company	14,360	1.25	1.00	1.75	Horizon Therapeutics reports Q3 earnings beat; raises FY22 guidance & peak annual net sales expectations [11/2/2022 7:04 AM]	70.45	7.27 (11.51%)	68.25	5.07 (8.02%)	57.84 - 120.00	6,838,209	2,570,000	27,252
Horizon Therapeutics reports Q3 earnings beat; raises FY22 guidance & peak annual net sales expectations [11/2/2022 7:04 AM] Horizon Therapeutics gains as strong sales for arthritis therapy prompt guidance raise [11/2/2022 8:34 AM] Horizon Therapeutics plc Reports Third-Quarter 2022 Financial Results; Increases Full-Year 2022 Net Sales and Adjusted EBITDA Guidance; Increases TEPEZZA and KRYSTEXXA Peak Annual Net Sales Expectations [Nov-02-22 07:00AM] Horizon Therapeutics plc Named to the Seramount Inclusion Index [Nov-01-22 09:00AM]
03-08-2022	PM	7:00 AM ET (Aug 3)	HZNP	Horizon Therapeutics Public Limited Company	19,060	1.07	1.34	1.62		66.92	-15.21 (-18.52%)	64.37	-17.76 (-21.62%)	60.76 - 120.53	18,320,461	1,430,000	1,410,992
Horizon Therapeutics Q2 2022 Earnings Preview [8/2/2022 12:22 PM] Horizon Therapeutics reports Q2 earnings miss; revises FY 2022 net sales and Adj.EBITDA guidance [8/3/2022 7:04 AM] Horizon Therapeutics plunges 22% on disappointing Q2 result, lowers 2022 sales guidance [8/3/2022 9:03 AM] Horizon Therapeutics plc Reports Second-Quarter 2022 Financial Results and Revises Full-Year 2022 Net Sales and Adjusted EBITDA Guidance [Aug-03-22 07:00AM]
04-05-2022	PM	7:00 AM ET (May 4)	HZNP	Horizon Therapeutics	22,587	1.34	1.27	0.00	Horizon Therapeutics Non-GAAP EPS of $1.34 beats by $0.20, revenue of $885.2M beats by $18.81M [5/4/2022 7:09 AM]	95.65	0.93 (0.98%)	89.00	-5.72 (-6.04%)	83.42 - 120.53	5,284,539	1,910,000	152,663
Horizon Therapeutics Q1 2022 Earnings Preview [5/3/2022 2:15 PM] Horizon Therapeutics says rheumatoid arthritis drug met main goal in mid-stage study [5/3/2022 9:37 AM] Horizon Therapeutics Non-GAAP EPS of $1.34 beats by $0.20, revenue of $885.2M beats by $18.81M [5/4/2022 7:09 AM] Are You a Value Investor? This 1 Stock Could Be the Perfect Pick [May-03-22 09:40AM] Topline Data for Dazodalibep (HZN-4920) Meets Primary Endpoint in Rheumatoid Arthritis [May-03-22 09:15AM] Horizon Therapeutics plc Reports First-Quarter 2022 Financial Results [May-04-22 07:00AM] HZNP or TECH: Which Is the Better Value Stock Right Now? [May-03-22 11:40AM]
01-03-2022	PM	7:00 AM ET (Mar 1)	HZNP	Horizon Therapeutics Public Limited Company	21,320	1.41	1.27	1.28	Horizon Therapeutics Non-GAAP EPS of $1.41 beats by $0.06, revenue of $1.01B beats by $14.1M; initiates FY22 guidance [3/1/2022 7:07 AM]	97.14	5.97 (6.54%)	95.00	3.83 (4.20%)	79.81 - 120.53	2,362,976	2,430,000	1,264
Horizon Therapeutics Q4 2021 Earnings Preview [2/28/2022 11:47 AM] Horizon Therapeutics Non-GAAP EPS of $1.41 beats by $0.06, revenue of $1.01B beats by $14.1M; initiates FY22 guidance [3/1/2022 7:07 AM] Horizon Therapeutics rises in premarket after earnings beat, 2022 guidance [3/1/2022 9:26 AM] Horizon Therapeutics plc Launches #RAREis Representation Program to Elevate Global Rare Disease Equity [Feb-28-22 11:29AM] Horizon Therapeutics plc Reports Fourth-Quarter 2021 and Full-Year 2021 Financial Results; Announces Full-Year 2022 Guidance [Mar-01-22 07:00AM]
03-11-2021	PM	7:00 AM ET (Nov 3)	HZNP	Horizon Therapeutics Public Limited Company	26,720	1.75	1.54	1.74	Horizon Therapeutics EPS beats by $0.21, beats on revenue [11/3/2021 7:04 AM]	116.40	-1.00 (-0.85%)	112.00	-5.40 (-4.60%)	66.41 - 120.53	2,448,057	1,860,000	26,314
Horizon Therapeutics Q3 2021 Earnings Preview [11/2/2021 12:04 PM] Horizon Therapeutics EPS beats by $0.21, beats on revenue [11/3/2021 7:04 AM] Horizon Therapeutics raises guidance; announces CFO succession [11/3/2021 9:25 AM] Horizon Therapeutics (HZNP) is a Top-Ranked Momentum Stock: Should You Buy? [Nov-02-21 10:00AM] Horizon Therapeutics plc Announces Chief Financial Officer Succession Plan [Nov-03-21 07:02AM] Horizon Therapeutics plc Reports Record Third-Quarter 2021 Financial Results; Increasing Full-Year 2021 Net Sales and Adjusted EBITDA Guidance [Nov-03-21 07:00AM] Horizon Pharma plc (HZNP) Q3 2021 Earnings Call Transcript [Nov-03-21 05:00PM] Horizon CEO: Growth Driver Tepezza 'Still At A Fraction' Of Expected Peak Sales [Nov-03-21 12:55PM]
04-08-2021	PM	7:00 AM ET (Aug 4)	HZNP	Horizon Therapeutics Public Limited Company	22,430	1.62	0.91	0.43	Horizon Therapeutics EPS beats by $0.75, beats on revenue [8/4/2021 7:08 AM]	107.51	7.75 (7.77%)	107.51	0.0 (0.00%)	60.82 - 111.33	4,138,832	1,370,000	25,727
Horizon Therapeutics Q2 2021 Earnings Preview [8/3/2021 1:01 PM] Horizon Therapeutics EPS beats by $0.75, beats on revenue [8/4/2021 7:08 AM] Horizon Therapeutics jumps 9% on Q2 beat; FY21 guidance raise tops consensus [8/4/2021 7:53 AM] Horizon Therapeutics plc Reports Record Second-Quarter 2021 Financial Results; Increasing Full-Year 2021 Net Sales and Adjusted EBITDA Guidance [Aug-04-21 07:00AM]
05-05-2021	PM	7:00 AM ET (May 5)	HZNP	Horizon Therapeutics Public Limited Company	21,210	0.03	0.07	0.44	Horizon Therapeutics EPS misses by $0.02, beats on revenue [5/5/2021 7:06 AM]	89.30	-1.43 (-1.58%)	89.30	0.0 (0.00%)	36.27 - 97.20	2,367,204	1,160,000	66,468
Horizon Therapeutics Q1 2021 Earnings Preview [5/4/2021 1:31 PM] Horizon Therapeutics EPS misses by $0.02, beats on revenue [5/5/2021 7:06 AM] Horizon updates full-year guidance to reflect Viela Bio acquisition [5/5/2021 9:01 AM] Was The Smart Money Right About Horizon Therapeutics (HZNP)? [May-04-21 01:59PM] Horizon Therapeutics plc Reports First-Quarter 2021 Financial Results; Updating Full-Year 2021 Net Sales Guidance and Full-Year Adjusted EBITDA Guidance to Incorporate Recently Acquired Viela Bio, Inc. [May-05-21 07:00AM] Is Horizon Therapeutics Public Limited Company (HZNP) A Smart Long-Term Buy? [May-05-21 12:53PM]
24-02-2021	PM	7:00 AM ET (Feb 24)	HZNP	Horizon Therapeutics Public Limited Company	18,490	1.28	1.05	0.56	Horizon Therapeutics EPS beats by $0.21, beats on revenue [2/24/2021 7:06 AM]	95.52	11.24 (13.34%)	87.28	3.00 (3.56%)	23.81 - 96.54	3,701,087	1,570,523	5,866
Horizon Therapeutics EPS beats by $0.21, beats on revenue [2/24/2021 7:06 AM] Horizon Therapeutics Q4 2020 Earnings Preview [2/23/2021 11:19 AM] Horizon Therapeutics shares rise on strong Q4 beat, FY forecast [2/24/2021 10:19 AM] Horizon Therapeutics plc Reports Record Fourth-Quarter and Full-Year 2020 Financial Results; Announces Full-Year 2021 Guidance [Feb-24-21 07:00AM]
02-11-2020	PM	7:00 AM ET (Nov 2)	HZNP	Horizon Therapeutics Public Limited Company	17,130	1.74	1.00	0.64	Horizon Therapeutics EPS beats by $0.77, beats on revenue [11/2/2020 7:02 AM]	73.58	-1.36 (-1.81%)	72.50	-2.43 (-3.24%)	23.81 - 86.67	5,220,571	2,335,061	96,593

05-08-2020	PM	7:00 AM ET (Aug 5)	HZNP	Horizon Therapeutics Public Limited Company	11,990	0.43	0.40	0.49	Horizon Therapeutics EPS beats by $0.04, beats on revenue [8/5/2020 7:06 AM]	72.66	10.87 (17.59%)	73.71	11.92 (19.29%)	22.84 - 73.50	3,928,193	1,923,101	176,452

06-05-2020	PM		HZNP	Horizon Therapeutics Public Limited Company	6,900	0.44	0.23	0.30	Horizon Pharma EPS beats by $0.19, beats on revenue [5/6/2020 7:02 AM]	37.38	1.08 (2.99%)	41.99	4.61 (12.33%)	22.69 - 39.10	2,132,402	1,855,550	95,507